• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disappearance of circulating anti-Xa activity after intravenous injection of standard heparin and of a low molecular weight heparin (CY 216) in normal and nephrectomized rabbits.

作者信息

Caranobe C, Barret A, Gabaig A M, Dupouy D, Sié P, Boneu B

出版信息

Thromb Res. 1985 Oct 1;40(1):129-33. doi: 10.1016/0049-3848(85)90357-3.

DOI:10.1016/0049-3848(85)90357-3
PMID:4089823
Abstract
摘要

相似文献

1
Disappearance of circulating anti-Xa activity after intravenous injection of standard heparin and of a low molecular weight heparin (CY 216) in normal and nephrectomized rabbits.
Thromb Res. 1985 Oct 1;40(1):129-33. doi: 10.1016/0049-3848(85)90357-3.
2
In vivo neutralization of low-molecular weight heparin fraction CY 216 by protamine.
Semin Thromb Hemost. 1985 Jul;11(3):318-22. doi: 10.1055/s-2007-1004385.
3
The disappearance of a low molecular weight heparin fraction (CY 216) differs from standard heparin in rabbits.低分子量肝素组分（CY 216）在兔体内的消除情况与标准肝素不同。
Thromb Res. 1987 Jun 15;46(6):845-53. doi: 10.1016/0049-3848(87)90076-4.
4
Are molecular weight and anti-Xa activity sufficient to predict the antithrombotic power of heparin fractions.
Thromb Res. 1986 Dec 1;44(5):709-12. doi: 10.1016/0049-3848(86)90172-6.
5
Comparison of the haemorrhagic effects of unfractionated heparin and a low molecular weight heparin fraction (CY 216) in rabbits.普通肝素与低分子量肝素片段（CY 216）对家兔出血作用的比较。
Thromb Res. 1986 Sep 15;43(6):691-5. doi: 10.1016/0049-3848(86)90107-6.
6
Effect of very low molecular weight heparin-derived oligosaccharides on lipoprotein lipase release in rabbits.极低分子量肝素衍生寡糖对兔脂蛋白脂肪酶释放的影响。
Atherosclerosis. 1986 Nov;62(2):151-8. doi: 10.1016/0021-9150(86)90061-4.
7
Comparative study on the effects of a low molecular weight heparin (CY 216) and standard heparin in low dosage on experimental venous thrombosis.低分子量肝素（CY 216）与低剂量标准肝素对实验性静脉血栓形成影响的比较研究
Haemostasis. 1987;17(4):201-5. doi: 10.1159/000215744.
8
The parallel effects of a very low molecular weight heparin (CY222) on anti Xa activity and thyroid hormone levels in blood.极低分子量肝素（CY222）对血液中抗Xa活性和甲状腺激素水平的平行作用。
Scott Med J. 1987 Jun;32(3):76-8. doi: 10.1177/003693308703200306.
9
[Preliminary study of the use of low-molecular weight heparin to prevent thrombotic risk].低分子量肝素预防血栓形成风险应用的初步研究
J Mal Vasc. 1986;11(4):330-7.
10
Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.通过单次静脉注射给予兔后对活化凝血因子X活性的抑制作用测定达那肝素钠、达肝素钠和肝素的药代动力学。
Arzneimittelforschung. 1998 Aug;48(8):818-21.

引用本文的文献

1
Influence of chronic kidney disease on anticoagulation levels and bleeding after primary percutaneous coronary intervention in patients treated with unfractionated heparin.普通肝素治疗的患者中，慢性肾脏病对直接经皮冠状动脉介入术后抗凝水平及出血的影响。
J Thromb Thrombolysis. 2016 Apr;41(3):441-51. doi: 10.1007/s11239-015-1255-x.
2
Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?亭扎肝素和其他低分子肝素：有何证据表明它们对肾脏清除率的依赖存在差异？
Exp Hematol Oncol. 2013 Aug 8;2:21. doi: 10.1186/2162-3619-2-21. eCollection 2013.
3
Heparin in interventional radiology: a therapy in evolution.
介入放射学中的肝素：一种不断发展的疗法。
Semin Intervent Radiol. 2005 Jun;22(2):95-107. doi: 10.1055/s-2005-871864.
4
Endothelial binding sites for heparin. Specificity and role in heparin neutralization.肝素的内皮结合位点。特异性及在肝素中和中的作用。
Biochem J. 1986 Sep 15;238(3):847-54. doi: 10.1042/bj2380847.
5
Characterization and cellular distribution of acidic peptide and oligosaccharide metal-binding compounds from kidneys.肾脏中酸性肽和寡糖金属结合化合物的表征及细胞分布
Biochem J. 1992 Feb 1;281 ( Pt 3)(Pt 3):835-41. doi: 10.1042/bj2810835.